Epstein Secrets

omething on the table." Reuters (10/22, Cornwell) reports, "Senate Republicans remained skeptical of a possible deal costing trillions of dollars." Senate Appropriations Chairman Shelby told reporters, "I think we're not going anywhere. A lot of talk, no action." The Washington Post (10/22, Werner, Stein, 14.2M) say

patients even as other drugs for the disease begin to reach the market." USA Today (10/22, Rice, 10.31M) reports that Gilead Chief Medical Officer Merdad Parsey EFTA00135821 said the drug has approvals or authorizations in around 50 countries. The New Ynrk TIMP4 (10/22, Levenson, 18.61M) reports the FDA's

-republicans-wary-idUSKBN2771VQ> (10/22, Cornwell) reports, "Senate Republicans remained skeptical of a possible deal costing trillions of dollars." Senate Appropriations Chairman Shelby told reporters, "I think we're not going anywhere. A lot of talk, no action." The Washington Post <https://vvww.washingtonpost.com/

ws/health/2020/10/22/fda-approves-remdesivir-covid-19- hospital-patients/3733648001/> (10/22, Rice, 10.31M) reports that Gilead Chief Medical Officer Merdad Parsey said the drug has approvals or authorizations in around 50 countries. The New York Times <https://www.nytimes.com/2020/10/22/us/remdesivir-fda-appr

omething on the table." Reuters (10/22, Cornwell) reports, "Senate Republicans remained skeptical of a possible deal costing trillions of dollars." Senate Appropriations Chairman Shelby told reporters, "I think we're not going anywhere. A lot of talk, no action." The Washington Post (10/22, Werner, Stein, 14.2M) say

patients even as other drugs for the disease begin to reach the market." USA Today (10/22, Rice, 10.31M) reports that Gilead Chief Medical Officer Merdad Parsey said the drug has approvals or authorizations in around 50 countries. EFTA00148471 The New York Times (10/22, Levenson, 18.61M) reports the FDA's